Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd - colecalciferol; ferrous as iron iii hydroxide polymaltose compl. - טיפות - colecalciferol 1333 iu/ml; ferrous as iron iii hydroxide polymaltose compl. 50 mg/ml - iron and multivitamins - iron and multivitamins - privention of iron deficiency anemia and vitamin d supplement for infants from 6-12 months of age.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - folic acid - טבליה - folic acid 5 mg - folic acid - folic acid - prevention and treatment of folic acid deficiency.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd - isosorbide-5-mononitrate - קפסולות בשחרור איטי - isosorbide-5-mononitrate 60 mg - isosorbide mononitrate - isosorbide mononitrate - prevention and treatment of angina pectoris.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - isosorbide-5-mononitrate - קפסולות בשחרור איטי - isosorbide-5-mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - prevention and treatment of angina pectoris.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - indapamide - טבליה - indapamide 2.5 mg - indapamide - indapamide - diuretic for the treatment of hypertension and fluid retention.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - enalapril maleate - טבליה - enalapril maleate 5 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure.to retard the development of symptomatic heart failure in asymptomatic patients with left ventrcular dysfunction.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - enalapril maleate - טבליה - enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventrcular dysfunction.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - enalapril maleate - טבליה - enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure.to retard the development of symptomatic heart failure in asymptomatic patients with left ventrcular dysfunction.

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - losartan potassium - טבליה - losartan potassium 50 mg - losartan - losartan - hypertension: losartan indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losartan on the primary composite end point

Israel - Tiếng Do Thái - Ministry of Health

cts chemical industries ltd, israel - losartan potassium - טבליה - losartan potassium 12.5 mg - losartan - losartan - hypertension : losartan is indicated for the treatment of hypertension. heart failure: losartan is indicated for the treatment of heart failure (nyha ii) when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended.